Vivek Patel, MD¹, Shakthi Bhaskar, MD¹, Stephen J. Schuster, MD², Loretta J. Nastoupil, MD³, Miguel-Angel Perales, MD⁴, Roni Shouval, MD, PhD⁴, Joseph P. McGuirk, DO⁵, Richard T. Maziarz, MD⁶, Andy Chen, MD, PhD⁷, Veronika Bachanova, MD, PhD⁸, David L. Porter, MD⁹, Michael R. Bishop, MD¹⁰, Peter A. Riedell, MD¹⁰ and Olalekan O. Oluwole, MBBS¹

¹Vanderbilt University Medical Center, Nashville, TN
²Division of Hematology-Oncology/Department of Medicine, University of Pennsylvania, Philadelphia, PA
³Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
⁴Adult Bone Marrow Transplant Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
⁶Knight Cancer Institute, Oregon Health and Science University, Portland, OR
⁷Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Science University, Portland, OR
⁸Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
⁹Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
¹⁰The David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL

Fleur A De Groot^1*, Jeanette K. Doorduijn, MD, PhD², Mirian Brink, PhD^3*, Ruben A.L. De Groen^1*, Lorraine M. De Haan^4*, Troy Noordenbos^4*, Aniko Sijs-Szabo^1*, King Hong Lam, MD, PhD^5*, Arjan Diepstra, M.D., Ph.D.⁶, Liane te Boome⁷, Valeska Terpstra^8*, Lara H. Böhmer, MD^9*, Josée M. Zijlstra, MD PhD¹⁰, Lianne Koens^11*, Marc Durian, MD^12*, Mirjam A. Oudshoorn^1*, Hendrik Veelken, MD, PhD ¹, Marjolein W.M. Van Der Poel¹³, Myrurgia Abdul Hamid^14*, Wendy B.C. Stevens, MD^15*, J L.M van Rooij^16*, Rimke Oostvogels, MD PhD^17*, Karen J. Neelis, MD^18*, Michiel van den Brand, MD^19*, F.J. Sherida H. Woei-a-Jin, MD MSc^20*, Thomas Tousseyn^21*, Daan Dierickx, MD^22*, Patty M. Jansen^4*, Marie Jose Kersten, MD, PhD^23,24, Jacoline Bromberg, MD^25*, Marcel Nijland, MD, PhD^26* and Joost S.P. Vermaat, MD, PhD¹

¹Department of Hematology, Leiden University Medical Center, Leiden, Netherlands
²Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
³Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands, Utrecht, Netherlands
⁴Department of Pathology, Leiden University Medical Center, Leiden, Netherlands
⁵Erasmus MC, Rotterdam, NLD
⁶Department of Pathology and Medical Biology, University of Groningen, Groningen, Netherlands
⁷Department of Hematology, Haaglanden Medisch Centrum, Den Haag, Netherlands
⁸Pathology, Haaglanden MC, Den Haag, Netherlands
⁹Department of Hematology, Haga Teaching Hospital, The Hague, Netherlands
¹⁰Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands, Amsterdam, Netherlands
¹¹Department of Pathology, Amsterdam UMC, AMC, Amsterdam, Netherlands
¹²Department of Hematology, St Elisabeth Hospital, Tilburg, Netherlands
¹³Maastricht University Medical Center, Maastricht, Netherlands
¹⁴Maastricht University, Urmond, NLD
¹⁵dept hematology, Radboud UMC, Nijmegen, Netherlands
¹⁶Neurology, University Medical Center Utrecht, Utrecht, Netherlands
¹⁷Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands
¹⁸Department of Radiotherapy, Leiden University Medical Center, Leiden, Netherlands
¹⁹Department of Pathology, Radboud University Medical Center, Nijmegen, Netherlands
²⁰Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium
²¹Department of Pathology, UZ Leuven, Leuven, Belgium
²²University Hospitals Leuven, Leuven, Belgium
²³Department of Hematology, Academic Medical Center, Amsterdam, Noord Holland, Netherlands
²⁴Lymphoma and Myeloma Center Amsterdam-LYMMCARE, Amsterdam, Netherlands
²⁵dept of Neuro-Oncology, Daniel den Hoed Cancer Ctr., Rotterdam, Netherlands
²⁶University Medical Center Groningen, Groningen, Netherlands

Edward Poynton^1,2*, Emily Chernucha^3*, James Day^2*, Catherine Prodger^4*, David Hopkins^5*, Pallav Rakesh^6*, Tess O’Neill^7*, Nisha Thakrar^2*, Ayse Akarca^8*, Sabine Pomplun^8*, Teresa Marafioti, MD^8*, Maria Calaminici, MD, PhD^1*, Sridhar Chaganti, MD^9*, Pam McKay, MBChB, FRCP, FRCPath^5*, Jeffery Smith, MBChB, MRCP, FRCPath^10*, Toby A. Eyre, MBChB, DipMedEd, MRCP, FRCPath, MD^11*, Nicolas Martinez-Calle^3*, Kate Cwynarski, MD^12*, Christopher P. Fox^13* and Jessica Okosun, PhD^1,7

¹Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
²Department of Clinical Haematology, University College London Hospital, London, United Kingdom
³Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
⁴Churchill Cancer Center, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
⁵Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
⁶Centre for Clinical Haematology, University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom
⁷Department of Haemato-Oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom
⁸Department of Histopathology, University College London Hospital, London, United Kingdom
⁹Department of Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom
¹⁰Clatterbridge Cancer Centre, Liverpool University Hospital, Liverpool, United Kingdom
¹¹Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center, Oxford, United Kingdom
¹²University College London Hospitals NHS Foundation Trust, London, United Kingdom
¹³Department of Hematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom

Joanna Zurko, MD¹, Geoffrey Shouse, PhD, DO², Pallawi Torka, MD³, Tamara K. Moyo, MD, PhD^4*, Jason T. Romancik, MD⁵, Imran A. Nizamuddin, MD⁶, Kaitlin Annunzio, DO⁷, Jieqi Liu, MD^8*, Stefan K. Barta, MD⁹, Robert Ferdman, MD^3*, Rahul Bhansali, MD^10*, Jonathon B. Cohen, MD, MS¹¹, Sayan Mullick Chowdhury, DO, PhD^12*, Nirav N. Shah, MD¹³, Elyse I. Harris, MD¹⁴, Vaishalee P. Kenkre, MD¹, McKenzie Sorrell, DO¹⁵, Brian T. Hess, MD¹⁵, Deborah M. Stephens, DO¹⁶, Lindsey A. Fitzgerald, MD¹⁷, Thomas A. Ollila, MD¹⁸, Ishan Roy^19*, Shuo Ma, MD²⁰, Jane N. Winter, MD²¹, Barbara Pro, MD²², Jonathan Moreira, MD²³, Leo I. Gordon, MD²³, Alexey V Danilov, MD²⁴, Andrew M. Evens, DO, MBA, MMSc²⁵, Narendranath Epperla, MD, MS²⁶ and Reem Karmali, MD, MSc²⁷

¹Carbone Cancer Center, University of Wisconsin, Madison, WI
²Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
³Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁴Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
⁵Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, GA
⁶Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL
⁷The Ohio State University, Columbus, OH
⁸Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ
⁹Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
¹⁰Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
¹¹Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
¹²Ohio State University Medical Center, Columbus, OH
¹³Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
¹⁴Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI
¹⁵Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
¹⁶Huntsman Cancer Institute, Salt Lake City, UT
¹⁷Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
¹⁸Lifespan Cancer Institute, Brown University, Providence, RI
¹⁹Northwestern University, Chicago, IL
²⁰Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL
²¹Feinberg School of Medicine, Northwestern University, Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
²²Division of Hematology and Oncology, Northwestern University, Chicago, IL
²³Department of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University Feinberg School of Medicine, Chicago, IL
²⁴City of Hope Comprehensive Cancer Center, Duarte, CA
²⁵Rutgers Cancer Institute of New Jersey, Warren, NJ
²⁶The Ohio State University Comprehensive Cancer Center, Columbus, OH
²⁷Division of Hematology/Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL

Gloria Iacoboni, MD^1*, Josu Iraola-Truchuelo^2*, Alberto Mussetti^3*, Paula Fernández-Caldas^4*, Víctor Navarro Garcés^5*, ANA Africa Martin Lopez^6*, Javier Delgado^7*, Ariadna Pérez Martínez^8*, Manuel Guerreiro, MD^9*, Ana Carolina Carolina Caballero Gonzalez, MD^10*, Nuria Martínez-Cibrián^11*, Hugo Daniel Luzardo Henriquez^12*, Jose M. Sanchez, MD^13*, Juan-Manuel Sancho, MD, PhD^14*, Pere Barba, MD^1*, Mi Kwon, MD, PhD^15*, Lucía López Corral, MD^6*, Rafael Hernani, MD^8*, Juan Luis Reguera, MD^7*, Anna Sureda³, Alejandro Martín García-Sancho, MD, PhD^6*, Mariana Bastos-Oreiro, MD, PhD^4* and Pau Abrisqueta, MD, PhD^1*

¹Vall d’Hebron University Hospital, Barcelona, Spain
²Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
³Hospital Duran i Reynals, Instituto Catalán de Oncología, L'Hospitalet De Llobregat, Barcelona, Spain
⁴Gregorio Marañon General University Hospital, Madrid, Spain
⁵Oncology Data Science (ODysSey) Group, Vall d’Hebron Institute of Oncology (VHIO), BARCELONA, Spain
⁶Hematology Department, Hospital Clínico Universitario de Salamanca (CAUSA/IBSAL), Salamanca, Spain
⁷Hospital Universitario Virgen del Rocío, Sevilla, Spain
⁸Hematology Department, Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain
⁹Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
¹⁰Hematology Department, Hospital de la Santa Creu i Sant Pau, BARCELONA, Spain
¹¹Hospital Clinic, Barcelona, ESP
¹²Hematology Department, Hospital Dr. Negrín, Las Palmas de Gran Canaria, Spain
¹³Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, ESP
¹⁴Clinical Hematology Department, Hospital Germans Trias i Pujol, Badalona, Spain
¹⁵Department of Hematology Institute of Health Research Gregorio Marañón, Hospital General Universitario Gregorio Marañón, Madrid, Spain

Paolo F Caimi, MD¹, Christine Auberle, MD², Krishna Goparaju, MD³, Firas Baidoun, MD⁴, Amanda F. Cashen, MD⁵ and Brian T. Hill, MD, PhD¹

¹Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
²Washington University School of Medicine, St. Louis
³University Hospitals- Case Western Reserve University, Cleveland, OH
⁴Division of Hematology and Medical Oncology, Mayo Clinic Florida, Westlake, OH
⁵Division of Oncology, Washington University School of Medicine, St. Louis, MO